Marlborough

Marlborough medical device maker Hologic is expecting revenues from subsidiary Cynosure to be about $15 million less after it halted sales of a device due to a government warning.

Patrick Sullivan, the CEO of the insulin device company building a $100 million facility in Acton, will retire at the end of the year.

Boston Scientific has announced its largest transaction this year: an acquisition of a Bedford prostate health firm for up to $600 million.

A Texas man on the National Do Not Call Registry is alleging Marlborough medical device giant Boston Scientific made unsolicited robocalls to him to market a spinal cord stimulation device.

In the 2018 WBJ 40 Under Forty class announced Monday, nine Central Massachusetts health professionals from organizations like UMass Memorial Health Care, Boston Scientific and Ascentria Care Alliance were among the winners.

Worcester's Flying Dreams Brewing Co. will open a second location into a space in Marlborough where a fledgling brewery failed to open the doors.

With this year's WBJ 40 Under Forty, you see the people who could turn the cultural renaissance from a well-started idea to a full-blown reality.

A commercial plaza on Route 20 in Marlborough has sold for $6.3 million to a Texas investment company.

A subsidiary of Marlborough medical device firm Hologic has landed the U.S. and Canadian distribution rights of a Pennsylvania medical equipment manufacturer's nitrous oxide and oxygen systems.

Despite reporting just $58,000 in second-quarter revenues, Marlborough drugmaker RXi Pharmaceuticals was able to significantly reduce its net loss, reduce its cash burn and extend its runway.